Aditya Birla Sun Life Mutual Fund
← All mutual funds

Aditya Birla Sun Life Pharma and Healthcare Fund - Direct Plan - GROWTH

Aditya Birla Sun Life Mutual Fund · Sectoral/Thematic · Direct · Growth

NAV · as of 11/09/2026

40.48

1D

-0.15%

1Y

+17.47%

Key stats

Expense ratio
0.80%
AUM
₹1.07 K Cr
Launched
11/07/2019
Fund manager
Dhaval Shah
Portfolio turnover
0.19%
Risk
Very High Risk
Min lump-sum
₹1,000
Min SIP
₹100/mo
Fresh lump-sum
Accepted
Fresh SIP
Accepted

NAV history

Aditya Birla Sun Life Pharma and Healthcare Fund - Direct Plan - GROWTH

13/08/2026 to 11/09/2026

O - H - L -

41.2340.4813/08/202611/09/2026
1W-0.27%
1M-1.15%
3M+8.32%
6M+18.99%
1Y+17.47%
3Y+21.98%
5Y+14.43%
MAX+302.79%

Top holdings

41 disclosed
  • 1.

    Sun Pharmaceuticals Industries Ltd

    Healthcare

    12.09%
  • 2.

    Apollo Hospitals Enterprise Ltd

    Healthcare

    7.30%
  • 3.

    J.B. Chemicals & Pharmaceuticals Ltd

    Healthcare

    4.71%
  • 4.

    Torrent Pharmaceuticals Ltd

    Healthcare

    4.68%
  • 5.

    Aurobindo Pharma Ltd

    Healthcare

    4.55%
  • 6.

    Ajanta Pharma Ltd

    Healthcare

    4.38%
  • 7.

    Mankind Pharma Ltd

    Healthcare

    3.92%
  • 8.

    Lupin Ltd

    Healthcare

    3.74%
  • 9.

    Sai Life Sciences Ltd

    Healthcare

    3.50%
  • 10.

    Abbott India Ltd

    Healthcare

    3.26%
  • 11.

    Emcure Pharmaceuticals Ltd

    Healthcare

    3.23%
  • 12.

    Fortis Healthcare Ltd

    Healthcare

    3.21%
  • 13.

    Cipla Ltd

    Healthcare

    2.93%
  • 14.

    Ipca Laboratories Ltd

    Healthcare

    2.55%
  • 15.

    Gland Pharma Ltd

    Healthcare

    2.48%
  • 16.

    Shilpa Medicare Ltd

    Healthcare

    2.41%
  • 17.

    Corona Remedies Ltd

    Healthcare

    2.28%
  • 18.

    Clearing Corporation Of India Limited

    2.26%
  • 19.

    Procter & Gamble Health Ltd

    Healthcare

    2.20%
  • 20.

    Alkem Laboratories Ltd

    Healthcare

    1.93%
  • 21.

    Thyrocare Technologies Ltd

    Healthcare

    1.93%
  • 22.

    Jupiter Life Line Hospitals Ltd

    Healthcare

    1.85%
  • 23.

    Divi's Laboratories Ltd

    Healthcare

    1.69%
  • 24.

    Dr. Lal PathLabs Ltd

    Healthcare

    1.59%
  • 25.

    Metropolis Healthcare Ltd

    Healthcare

    1.44%
  • 26.

    Sanofi Consumer Healthcare India Ltd

    Healthcare

    1.44%
  • 27.

    Dr Reddy's Laboratories Ltd

    Healthcare

    1.33%
  • 28.

    Pfizer Ltd

    Healthcare

    1.23%
  • 29.

    Biocon Ltd

    Healthcare

    1.12%
  • 30.

    Anthem Biosciences Ltd

    Healthcare

    1.08%
  • 31.

    Piramal Pharma Ltd

    Healthcare

    1.06%
  • 32.

    Vijaya Diagnostic Centre Ltd

    Healthcare

    1.05%
  • 33.

    Medi Assist Healthcare Services Ltd

    Healthcare

    0.95%
  • 34.

    Suraksha Diagnostic Ltd

    Healthcare

    0.90%
  • 35.

    Vinati Organics Ltd

    Basic Materials

    0.85%
  • 36.

    Syngene International Ltd

    Healthcare

    0.82%
  • 37.

    GlaxoSmithKline Pharmaceuticals Ltd

    Healthcare

    0.79%
  • 38.

    Max Healthcare Institute Ltd Ordinary Shares

    Healthcare

    0.78%
  • 39.

    Jubilant Pharmova Ltd

    Healthcare

    0.61%
  • 40.

    Net Receivables / (Payables)

    0.11%
  • 41.

    Alembic Pharmaceuticals Ltd

    -

Sector allocation

  • Healthcare97.01%
  • Unclassified2.37%
  • Basic Materials0.85%

Comparable peers

  • SBI Healthcare Opportunities Growth Direct Plan

    SBI Healthcare Opportunities (G) · ₹5.80 K Cr AUM

    1Y+22.13%
    3Y+24.61%
    -

  • Mirae Asset Healthcare Growth Direct Plan

    Mirae Healthcare (G) · ₹3.44 K Cr AUM

    1Y+20.35%
    3Y+23.20%
    -

  • Aditya Birla Sunlife Life Pharma & Healthcare Growth Direct Plan

    Aditya Birla Sunlife Life Pharma & Healthcare (G) · ₹1.07 K Cr AUM

    1Y+17.78%
    3Y+21.99%
    -

  • UTI Healthcare Growth Direct Plan

    UTI Healthcare (G) · ₹1.44 K Cr AUM

    1Y+17.28%
    3Y+24.42%
    -

  • HDFC Transportation & Logistics Growth Direct Plan

    HDFC Transportation & Logistics (G) · ₹1.96 K Cr AUM

    1Y+9.79%
    3Y+25.46%
    -

Investment objective

The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.

Scheme details

Scheme code
147409
Fund house
Aditya Birla Sun Life Mutual Fund
Category
Open Ended
Type
Equity Scheme
Sub-category
Sectoral/Thematic
Plan
Direct
Return type
Growth
ISIN (Growth)
INF209KB1O25
ISIN (Div. Reinvest)
-
Tradable on exchange
No

Kuvera page